{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-022537","form_type":"8-K","ticker":"TSEOF","cik":"0001519061","company_name":"Trinseo PLC","filed_at":"2026-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.301133+00:00","generated_at":"2026-05-15T22:14:28.005232+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"NYSE commences delisting proceedings for Trinseo after market cap falls below $15M","bullets":["Received NYSE notice on March 2, 2026; trading suspended immediately due to average market cap < $15M over 30 days.","Previously disclosed non-compliance: average market cap below $50M and share price below $1.00 in December 2025.","Delisting effective 10 days after NYSE files Form 25; shares may trade on OTC Pink, but no assurance.","Irish stamp duty of 1% applies on trades; DTC will cease clearing trades, requiring direct registration with transfer agent.","Company states delisting does not affect business operations, relationships, or SEC reporting obligations."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-022537","json":"https://secwatch.observer/filing/0001104659-26-022537.json","markdown":"https://secwatch.observer/filing/0001104659-26-022537.md","text":"https://secwatch.observer/filing/0001104659-26-022537.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1519061/000110465926022537/0001104659-26-022537-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1519061/000110465926022537/tse-20260302x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T22:14:28.005232+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0a794b87e8b029fed8d2edb640f9f77e9f6a1382","claim":"Trinseo PLC received a nyse delisting notice notice regarding other (rules 802.01B).","evidence_excerpt":"“Company”) received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the NYSE had determined to commence proceedings to delist the Company’s ordinary shares. As stated in the Notice, the NYSE reached its decision to delist the Company’s securities pursuant to Section 802.01B of the NYSE Listed Company Manual because the Company had fallen below the NYSE continued listing standard requiring listed companies to maintain an average market capitalization over a 30-trading day period of at least $15 million. The Notice also stated that trading in the Company’s ordina","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1519061/000110465926022537/0001104659-26-022537-index.htm","confidence":0.9},{"claim_id":"8b3507d1cb80a264cc3678641d4ddb0ae9d5237c","claim":"Trinseo PLC received a nyse delisting notice notice regarding minimum bid price (rules 802.01C).","evidence_excerpt":"ive 30 trading-day period was less than $50 million and, at the same time, its stockholders’ equity was less than $50 million. In addition, the Company also received written notice from the NYSE indicating that it was not in compliance with the NYSE’s continued listing standard set forth in Section 802.01C because its average closing share price had fallen below $1.00 per share for 30 consecutive trading days. ​ As stated in the Notice, the NYSE will file a Form 25 with the SEC to delist the Company’s ordinary shares from the NYSE upon completion of applicable procedures. The delisting will be","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1519061/000110465926022537/0001104659-26-022537-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001493152-26-025433","ticker":"SONM","company_name":"DNA X, Inc.","filed_at":"2026-05-27T20:35:28+00:00","headline":"DNA X receives Nasdaq delisting notice; issues $3.05M convertible note to insider","event_type":"regulatory","sec_items":["1.01","2.03","3.01","3.02","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-025433","json":"https://secwatch.observer/filing/0001493152-26-025433.json","markdown":"https://secwatch.observer/filing/0001493152-26-025433.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226025433/0001493152-26-025433-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226025433/form8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"“Company”) received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the NYSE had determined to commence proceedings to delist the Company’s ordinary shares. As stated in the Notice, the NYSE reached its decision to delist the Company’s securities pursuant to Section 802.01B of the NYSE Listed Company Manual because the Company had fallen below the NYSE continued listing standard requiring listed companies to maintain an average market capitalization over a 30-trading day period of at least $15 million. The Notice also stated that trading in the Company’s ordina","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1519061/000110465926022537/0001104659-26-022537-index.htm","comparable_excerpt":"May 22, 2026, the Company received a delisting determination letter from the Staff advising the Company that unless the Company requests\na hearing before a Nasdaq Hearing Panel (the “Panel”) to appeal Nasdaq’s delisting","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226025433/0001493152-26-025433-index.htm"}},{"accession":"0001213900-26-053904","ticker":"ADTX","company_name":"Aditxt, Inc.","filed_at":"2026-05-08T23:59:59+00:00","headline":"Aditxt receives Nasdaq delisting notice for bid price non-compliance; to appeal","event_type":"regulatory","sec_items":["3.01","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-053904","json":"https://secwatch.observer/filing/0001213900-26-053904.json","markdown":"https://secwatch.observer/filing/0001213900-26-053904.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026053904/0001213900-26-053904-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026053904/ea0289662-8k_aditxt.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"“Company”) received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the NYSE had determined to commence proceedings to delist the Company’s ordinary shares. As stated in the Notice, the NYSE reached its decision to delist the Company’s securities pursuant to Section 802.01B of the NYSE Listed Company Manual because the Company had fallen below the NYSE continued listing standard requiring listed companies to maintain an average market capitalization over a 30-trading day period of at least $15 million. The Notice also stated that trading in the Company’s ordina","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1519061/000110465926022537/0001104659-26-022537-index.htm","comparable_excerpt":"May 6, 2026, Aditxt, Inc. (the “Company”)\nreceived a Staff Determination letter (the “Staff Determination”) from the Listing Qualifications Department of The Nasdaq\nStock Market LLC (“Nasdaq”) notifying the Company that","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026053904/0001213900-26-053904-index.htm"}},{"accession":"0001193125-26-237207","ticker":"TPST","company_name":"Tempest Therapeutics, Inc.","filed_at":"2026-05-22T21:28:16+00:00","headline":"Tempest Therapeutics warned by Nasdaq for low equity and board independence; two directors resign","event_type":"regulatory","sec_items":["3.01","5.02"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-237207","json":"https://secwatch.observer/filing/0001193125-26-237207.json","markdown":"https://secwatch.observer/filing/0001193125-26-237207.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1544227/000119312526237207/0001193125-26-237207-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1544227/000119312526237207/d131489d8k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"“Company”) received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the NYSE had determined to commence proceedings to delist the Company’s ordinary shares. As stated in the Notice, the NYSE reached its decision to delist the Company’s securities pursuant to Section 802.01B of the NYSE Listed Company Manual because the Company had fallen below the NYSE continued listing standard requiring listed companies to maintain an average market capitalization over a 30-trading day period of at least $15 million. The Notice also stated that trading in the Company’s ordina","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1519061/000110465926022537/0001104659-26-022537-index.htm","comparable_excerpt":"May 22, 2026, Tempest Therapeutics, Inc. (the “Company”) notified the Nasdaq Stock Market LLC (“Nasdaq”) that the Company will not be in compliance with the majority independent director requirement under Nasdaq Listing","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1544227/000119312526237207/0001193125-26-237207-index.htm"}},{"accession":"0001654954-26-005160","ticker":"TOMZ","company_name":"TOMI Environmental Solutions, Inc.","filed_at":"2026-05-20T13:00:39+00:00","headline":"TOMI Environmental receives Nasdaq delisting notice for bid price, equity non-compliance","event_type":"regulatory","sec_items":["3.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-26-005160","json":"https://secwatch.observer/filing/0001654954-26-005160.json","markdown":"https://secwatch.observer/filing/0001654954-26-005160.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/314227/000165495426005160/0001654954-26-005160-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/314227/000165495426005160/tomz_8k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"“Company”) received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the NYSE had determined to commence proceedings to delist the Company’s ordinary shares. As stated in the Notice, the NYSE reached its decision to delist the Company’s securities pursuant to Section 802.01B of the NYSE Listed Company Manual because the Company had fallen below the NYSE continued listing standard requiring listed companies to maintain an average market capitalization over a 30-trading day period of at least $15 million. The Notice also stated that trading in the Company’s ordina","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1519061/000110465926022537/0001104659-26-022537-index.htm","comparable_excerpt":"May 19, 2026, the Company received a letter (the “Letter”) from the Listing Qualifications Department (the “Staff”) of Nasdaq notifying the Company that because it failed to regain compliance with each of the Bid Price R","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/314227/000165495426005160/0001654954-26-005160-index.htm"}},{"accession":"0001213900-26-054487","ticker":"PRPL","company_name":"Purple Innovation, Inc.","filed_at":"2026-05-11T20:15:35+00:00","headline":"Purple Innovation receives Nasdaq delisting determination; will appeal by May 12","event_type":"regulatory","sec_items":["3.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-054487","json":"https://secwatch.observer/filing/0001213900-26-054487.json","markdown":"https://secwatch.observer/filing/0001213900-26-054487.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1643953/000121390026054487/0001213900-26-054487-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1643953/000121390026054487/ea0290110-8k_purple.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"“Company”) received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the NYSE had determined to commence proceedings to delist the Company’s ordinary shares. As stated in the Notice, the NYSE reached its decision to delist the Company’s securities pursuant to Section 802.01B of the NYSE Listed Company Manual because the Company had fallen below the NYSE continued listing standard requiring listed companies to maintain an average market capitalization over a 30-trading day period of at least $15 million. The Notice also stated that trading in the Company’s ordina","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1519061/000110465926022537/0001104659-26-022537-index.htm","comparable_excerpt":"May 5, 2026, Purple Innovation, Inc. (the “Company”)\nreceived a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as\nnotified by Nasdaq on November 5, 2025, the bid price of the Company’s Class A common stock had closed at less than $1.00 per share\nover the previous 30 consecutive business days, and, as a result, did not comply with Listing Rule 5450(a)(1) (the “Minimum Bid\nPrice Requirement”). In accordance with Listing Rule 5810(c)(3)(A), the Company was provided 180 calendar days, or until May 4,\n2026, to regain compliance with the","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1643953/000121390026054487/0001213900-26-054487-index.htm"}},{"accession":"0001193125-26-251421","ticker":"GENC","company_name":"GENCOR INDUSTRIES INC","filed_at":"2026-06-01T20:09:26+00:00","headline":"Gencor receives NYSE American delinquency notice for late Q2 2026 10-Q filing","event_type":"regulatory","sec_items":["3.01","7.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","same event type: regulatory"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251421","json":"https://secwatch.observer/filing/0001193125-26-251421.json","markdown":"https://secwatch.observer/filing/0001193125-26-251421.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/64472/000119312526251421/0001193125-26-251421-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/64472/000119312526251421/d135716d8k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"“Company”) received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the NYSE had determined to commence proceedings to delist the Company’s ordinary shares. As stated in the Notice, the NYSE reached its decision to delist the Company’s securities pursuant to Section 802.01B of the NYSE Listed Company Manual because the Company had fallen below the NYSE continued listing standard requiring listed companies to maintain an average market capitalization over a 30-trading day period of at least $15 million. The Notice also stated that trading in the Company’s ordina","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1519061/000110465926022537/0001104659-26-022537-index.htm","comparable_excerpt":"May 19, 2026, Gencor Industries, Inc. (the “Company”) received a notice (the “Delinquency Notification”) from NYSE Regulation (the “NYSE”) indicating the Company was not in compliance with the NYSE American LLC (“NYSE American”) continued listing standards as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”) with the Securities and Exchange Commission (“SEC”) prior to May 18, 2026, the end of the extension period provided by Form 12b-25, and as a result was subject to the procedures set forth in Section 1007 of the NY","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/64472/000119312526251421/0001193125-26-251421-index.htm"}},{"accession":"0001213900-26-062935","ticker":"ATNM","company_name":"Actinium Pharmaceuticals, Inc.","filed_at":"2026-05-29T21:10:41+00:00","headline":"Actinium receives NYSE American non-compliance notice for low stockholders' equity; must submit plan by June 26","event_type":"regulatory","sec_items":["3.01","7.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","same event type: regulatory"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-062935","json":"https://secwatch.observer/filing/0001213900-26-062935.json","markdown":"https://secwatch.observer/filing/0001213900-26-062935.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1388320/000121390026062935/0001213900-26-062935-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1388320/000121390026062935/ea0292691-8k_actinium.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"“Company”) received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the NYSE had determined to commence proceedings to delist the Company’s ordinary shares. As stated in the Notice, the NYSE reached its decision to delist the Company’s securities pursuant to Section 802.01B of the NYSE Listed Company Manual because the Company had fallen below the NYSE continued listing standard requiring listed companies to maintain an average market capitalization over a 30-trading day period of at least $15 million. The Notice also stated that trading in the Company’s ordina","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1519061/000110465926022537/0001104659-26-022537-index.htm","comparable_excerpt":"May 27, 2026, Actinium Pharmaceuticals, Inc.\n(the “Company”) received a notice (the “Notice”) from NYSE American LLC (“NYSE American”) indicating\nthat the Company is not in compliance with the continued listing standards set forth in Section 1003(a)(ii) of the NYSE American Company\nGuide (the “Company Guide”), which requires a listed company to maintain stockholders’ equity of $4.0 million or more\nif it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. As of March 31,\n2026, the Company reported stockholders’ equity of approximately","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390026062935/0001213900-26-062935-index.htm"}},{"accession":"0001683168-26-004399","ticker":"CSAI","company_name":"CLOUDASTRUCTURE, INC.","filed_at":"2026-05-29T21:09:11+00:00","headline":"Cloudastructure receives Nasdaq delinquency notice for late Q1 10-Q filing","event_type":"regulatory","sec_items":["3.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","same event type: regulatory"],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-004399","json":"https://secwatch.observer/filing/0001683168-26-004399.json","markdown":"https://secwatch.observer/filing/0001683168-26-004399.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1709628/000168316826004399/0001683168-26-004399-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1709628/000168316826004399/cloud_8k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"“Company”) received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the NYSE had determined to commence proceedings to delist the Company’s ordinary shares. As stated in the Notice, the NYSE reached its decision to delist the Company’s securities pursuant to Section 802.01B of the NYSE Listed Company Manual because the Company had fallen below the NYSE continued listing standard requiring listed companies to maintain an average market capitalization over a 30-trading day period of at least $15 million. The Notice also stated that trading in the Company’s ordina","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1519061/000110465926022537/0001104659-26-022537-index.htm","comparable_excerpt":"May 26, 2026, Cloudastructure,\nInc. (the “Company”) received a notice (the “Notice”) from the Nasdaq Listing Qualifications staff of The Nasdaq\nStock Market LLC (“Nasdaq”) indicating that, as a result of not having timely filed its Quarterly Report on Form 10-Q for\nthe period ended March 31, 2026 (“Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which\nrequires timely filing of all required periodic financial reports with the Securities and Exchange Commission. The Company requires additional\ntime to review and confirm the accounting treatment for its outstand","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1709628/000168316826004399/0001683168-26-004399-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}